Let’s look into brief profile of CYCC. Cyclacel Pharmaceuticals, Inc has various drugs under develipment: they are: Sapacitabine (CYC682): An oral nucleoside analogue, which is in phase II studies for the treatment of hematological malignancies, , such as acute myeloid leukemia in the elderly, myelodysplastic syndromes, cutaneous T-cell lymphoma, and lung cancer. Seliciclib (CYC202): A [...]
{ 0 comments }
BEIJING, Nov. 17 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA – News), a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company’s H1N1 vaccine. The population has been expanded to include people over 60 years old. The [...]
{ 1 comment }
Drug development and FDA approval process is very crucial for every Biotech Company. If you intend to buy any Biotech stock, keep your eyes wide open on FDA news. Knowing FDA news help you to make huge profit from trading Biotech stocks. American consumers benefit from having access to the safest and most advanced pharmaceutical system in the world.
{ 0 comments }